These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1008 related items for PubMed ID: 18945413

  • 21. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP.
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [Abstract] [Full Text] [Related]

  • 22. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.
    Franco EL, Cuzick J, Hildesheim A, de Sanjosé S.
    Vaccine; 2006 Aug 31; 24 Suppl 3():S3/171-7. PubMed ID: 16844268
    [Abstract] [Full Text] [Related]

  • 23. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.
    Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer DL.
    Qual Health Res; 2008 May 31; 18(5):584-96. PubMed ID: 18337618
    [Abstract] [Full Text] [Related]

  • 24. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Wheeler CM.
    Nat Clin Pract Oncol; 2007 Apr 31; 4(4):224-35. PubMed ID: 17392713
    [Abstract] [Full Text] [Related]

  • 25. The current and future role of screening in the era of HPV vaccination.
    Myers E, Huh WK, Wright JD, Smith JS.
    Gynecol Oncol; 2008 May 31; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [Abstract] [Full Text] [Related]

  • 26. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M, Sasieni P, Cuzick J.
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct 31; 25(5):617-29. PubMed ID: 21683657
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
    Downs LS, Scarinci I, Einstein MH, Collins Y, Flowers L.
    Gynecol Oncol; 2010 Jun 31; 117(3):486-90. PubMed ID: 20303156
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
    Dillner L, Pagliusi S, Bray F, Lorincz A, Kjaer SK, Anttila A, Iversen OE, Dillner J, Lehtinen M, Paavonen J.
    Acta Obstet Gynecol Scand; 2008 Jun 31; 87(5):489-98. PubMed ID: 18446530
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.
    Cytopathology; 2009 Aug 31; 20(4):249-55. PubMed ID: 19018810
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M.
    Cancer; 2007 Jun 25; 111(3):145-53. PubMed ID: 17487850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.